EGFR and neoplasm: Although parthenolide suppressed in vivo tumor growth of lung cancer by targeting NF-κB target and inducing ROS [19], the basic oncogenic role of EGFR in NSCLC and its specific pharmacological of parthenolide in NSCLC is little known.